| Don’t let financial matters get in the way of your treatment.
|
|
| Dear John Doe,
It’s that time of year again–time to think about reviewing your COPAXONE® (glatiramer acetate injection) insurance benefits. Whether your financial situation or benefits have changed, or you’re just trying to understand the new federal health care policies, Shared Solutions® is here to provide free, personalized service to help you gain access to COPAXONE® therapy. The COPAXONE Co-pay Solutions® program provides affordable access to COPAXONE®. If you have private insurance and your out-of-pocket costs are more than $35 per month, your co-pay could be lowered to $35 per month. If your insurance has recently changed, contact Shared Solutions® to see if COPAXONE Co-pay Solutions® is right for you. |
|
YOU COULD PAY NO MORE THAN $35 PER MONTH*
|
|
If COPAXONE Co-pay Solutions® isn’t right for you, there are other ways we may be able to help. You can trust Shared Solutions® to put you on the right track to access by providing: |
|||
| • | Financial assistance you need to start and stay on COPAXONE® | ||
| • | Assistance in navigating Medicare Part D | ||
| • | Assistance if you are uninsured or underinsured | ||
| • | Insurance and benefits investigation | ||
| • | Pharmacy benefits research to help determine the most convenient way for you to receive COPAXONE® | ||
|
We’ve recently enhanced our financial services to help even more people start and stay on COPAXONE®. Find out if recent changes we’ve made to our program can further assist you with additional savings. We’ll be happy to reassess your needs. See if COPAXONE Co-pay Solutions® is right for you. Call Shared Solutions® at 1-800-887-8100. Have your insurance card, prescription card, and tax forms on hand when you call. Your Shared Solutions® Team 
*Certain limits and restrictions apply. Terms and Conditions: COPAXONE Co-pay Solutions® is open to both new and existing patients who are residents of the US or Puerto Rico and who have private insurance coverage. The offer is not valid for patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void where prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time without notice. This program is not health insurance. Please see Important Safety Information about COPAXONE® below. COPAXONE® (glatiramer acetate injection) is indicated for reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis (RRMS), including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis. Important Safety Information about COPAXONE® |
|||
| • | Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol
|
||
| • | Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again
|
||
| • | Chest pain may occur either as part of the immediate postinjection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense
|
||
| • | A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes
|
||
| • | The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®
|
||
| You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
Please see full Prescribing Information. Privacy Policy | Unsubscribe | Terms of Use | Contact Us 
COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered service mark of Teva Neuroscience, Inc. COPAXONE CO-PAY SOLUTIONS® is a registered trademark of Teva Pharmaceutical Industries Ltd. Teva Neuroscience, Inc., Copaxone Marketing, 11100 Nall Avenue, Overland Park, Kansas 66211 © 2013 Teva Neuroscience, Inc. COP-40588 |
|||